What are Monoclonal Antibodies?

[00:00:00]Welcome to this video on Precision Strike, where we explore monoclonal antibodies as medicines' guided missiles.

[00:00:05]>> [music] >> This content is for general awareness and is not a technical handout or treatment guide. We are witnessing a paradigm shift from the shotgun era to the precision era. Traditional treatments cause systemic collateral damage. Monoclonal antibodies, or mAbs, seek out a specific biological target, minimizing off-target casualties. The antibody acts as a modular Y chassis.

[00:00:27]The Fab, or variable region, serves as guidance sensors, engineered to lock onto one specific antigen. The hinge region is the flexible airframe, allowing for optimal target engagement.

[00:00:38]Finally, the Fc, or constant region, acts as the engine and payload bay. Our first mission profile is search and destroy for targeted cancer therapy. The delivery vehicle is a monoclonal antibody, >> [music] >> the trigger is a chemical linker, and the warhead is a cytotoxic payload. An example is trastuzumab deruxtecan. The detonation sequence involves Trojan horse infiltration. First, the antibody-drug conjugate binds to the tumor antigen.

[00:01:03]>> [music] >> Then, the tumor cell internalizes the complex, and lysosomal enzymes cleave the linker. Finally, the payload triggers apoptosis and a bystander effect. Mission profile two is intercept and diffuse for autoimmune diseases. The threat is the overproduction of inflammatory signals, such as [music] TNF alpha. The weapon is naked monoclonal antibodies, like adalimumab or infliximab, which act as biological signal jammers.

[00:01:28]>> [music] >> The intercept sequence is about neutralizing the signal. The mAbs deploy, seeking out free-floating inflammatory cytokines. The diffusal involves steric hindrance, where the mAb prevents the cytokine from docking with cell surface receptors, halting the inflammatory cascade.

[00:01:42]>> [music] >> In review, both missions utilize a singular technology, but with different applications. Search and destroy uses antibody-drug conjugates for targeted cell death in cancer. Intercept and diffuse uses naked monoclonal antibodies to suppress inflammation in autoimmunity. The monoclonal antibody represents an adaptable, programmable platform, not just a drug. We can program interchangeable coordinates by engineering the variable region and dictate the outcome through modular payloads. The future of medicine lies in determining the next coordinates to program. [music] Once again, this content is for supplementary information for medical students and is not intended for clinical guidance, use in medical clinics, or patient management.